Texas Medical Center and Biodesign Australia join hands to enhance healthcare innovation


A major partnership between Texas Medical Center (TMC) and Biodesign Australia has been announced, aimed at advancing health and medical life sciences innovation and entrepreneurship.

Biodesign Australia is a network administered by the University of Western Australia (UWA), allowing Biodesign programs in Perth, Melbourne, Sydney, Adelaide and Brisbane to share resources, speakers and best practice to provide a quality experience for participants and innovations for patients.

TMC and Biodesign Australia will work collaboratively to facilitate opportunities between TMC Biodesign and programs within the Biodesign Australia network.

Founders and entrepreneurs will be provided with access to talent, clinical trial activity, expanded funding opportunities and market access. This announcement builds on the TMC/Australian BioBridge, which was launched in 2018.

The global partnership comes as the McGowan Government has recently announced $8.65 million in funding to implement the State’s first ever Health and Medical Life Sciences Industry Strategy.

The strategy, which was launched last year, provides a blueprint to develop and grow the sector and diversify WA’s economy.

The strategy outlined the growth potential of health and medical life sciences to create highly skilled jobs and improve patient outcomes, building on WA’s many strengths as an investment, research and manufacturing hub.

Next Post

How is AI moving the needle in the pharmaceutical industry?

Artificial intelligence can help drug study teams solve operational, scientific and ethical challenges. For example, AI can be used to flag real-time trends emerging in drug trials that might otherwise not be obvious until the end of a study when all the data is analyzed. Artificial intelligence (AI) is shaking […]